BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures
BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today…
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency
Application is based on data from the pivotal Phase 3 AENEAS trial evaluating aumolertinib as…
Arboretum_JDDecember 2, 2022
RareCyte® selected for the Wellcome Leap In Utero program
RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services…
Arboretum_JDNovember 16, 2022
Fifth Eye Announces Andrew Malcolmson as new President & CEO
Fifth Eye™, a leading provider of real-time AI-based clinical analytics today announced that its Board…
Arboretum_JDNovember 2, 2022
Bioelectronic Medicine Company Boomerang Medical Raises $15M in Series A Financing
Returning investor Arboretum Ventures, joined by Hatteras Venture Partners, to fuel Boomerang Medical’s accelerated clinical…
Arboretum_JDNovember 1, 2022
Convergent Dental Receives FDA 510 (k) Clearance for First and Only Dental Laser to Aid in the Reduction of Mineral Loss in Dental Enamel
Convergent Dental, Inc., the power behind the Solea® All-Tissue Dental Laser, today announced it has…
Arboretum_JDOctober 12, 2022
ViaLase Founder and CEO Tibor Juhasz, PhD, Receives 2022 Golden Goose Award
ViaLase, Inc., announced that the company’s founder and CEO, Tibor Juhasz, Ph.D., was among five…
Arboretum_JDOctober 11, 2022
Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Arboretum_JDOctober 4, 2022
Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening
Delphinus Medical Technologies, Inc. today announced the closing of a $30 million Series D financing to…
Arboretum_JDSeptember 30, 2022